RLMD

Relmada Therapeutics, Inc. - Common Stock (RLMD)

About Relmada Therapeutics, Inc. - Common Stock (RLMD)

Relmada Therapeutics, Inc. engages in the development of clinical-stage drugs. The firm's pipeline includes NDV-01 and Sepranolone. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Details

Daily high

$4.17

Daily low

$4.06

Price at open

$4.15

52 Week High

$8.00

52 Week Low

$1.47

Market cap

439.5M

Dividend yield

Volume

2.1M

Avg. volume

1.3M

P/E ratio

-4.43

Relmada Therapeutics, Inc. - Common Stock News